Corvex Management Portfolio holdings
Corvex Management runs private investment funds. Keith Meister, who earlier worked at Icahn Enterprises, formed the firm in December 2010 and is its principal owner. It follows an event-driven approach, studying a company's business and credit and looking for a catalyst, and often seeks to be an active investor that works with portfolio companies. An affiliate, Corvex PE, advises funds for longer-term investments, including take-private deals.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto
MON
|
+$352M |
| 2 |
Intercontinental Exchange
ICE
|
+$233M |
| 3 |
Lamar Advertising
LAMR
|
+$112M |
| 4 |
Anadarko Petroleum
APC
|
+$94.2M |
| 5 |
AGN
Allergan plc
AGN
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$293M |
| 2 |
American Tower
AMT
|
+$172M |
| 3 |
LVLT
Level 3 Communications
LVLT
|
+$141M |
| 4 |
Danaher
DHR
|
+$129M |
| 5 |
HCA Healthcare
HCA
|
+$116M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 32.08% |
| 2 | Miscellaneous | 18.73% |
| 3 | Financials | 9.79% |
| 4 | Healthcare | 8.01% |
| 5 | Real Estate | 8.01% |
Similar funds
Corvex Management's Q2 2014 Portfolio in Review
As of Q2 2014, Corvex Management held 70 positions worth $8.43B, up 18% from $7.13B the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Corvex Management withdrew a net $285M in Q2 2014, closing 26 positions and reducing 9 holdings. Its most notable exit was Thermo Fisher Scientific, an estimated $293M position sold in full.
By sector, the portfolio is most concentrated in Energy at 32% of assets, up from 27% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Corvex Management opened a new position in Intercontinental Exchange worth $226M.
- Corvex Management's largest Q2 2014 buy was Intercontinental Exchange: 5,981,065 shares worth $226M.
- Corvex Management added most to Monsanto in Q2 2014, an estimated $352M increase.
- Corvex Management's biggest Q2 2014 reduction was Level 3 Communications, cutting an estimated $141M.
- Corvex Management fully exited Thermo Fisher Scientific in Q2 2014, selling an estimated $293M.
- Corvex Management's ten largest holdings make up 68% of its $8.43B portfolio in Q2 2014.
- Corvex Management opened 13 new positions and closed 26 in Q2 2014.
- Corvex Management's portfolio value rose 18% quarter-over-quarter to $8.43B.
Based on Corvex Management's 13F filing for Q2 2014, filed 14 Aug 2014.